Article
Engineered antibodies take center stage
31 Dec 2001
Abstract excerpt
The start of the post-genomic era provides a useful juncture for reflection on the state of antibody engineering, which will be a critical technology for relating function and pathology to genomic sequence in biology and medicine. The phenomenal progress in deciphering the human genome has given significant impetus to the application of engineered antibodies in proteomics. Thus, advances in phage display antibody...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
